DK3019185T3 - Kombinationsbehandling for atopisk dermatitis - Google Patents

Kombinationsbehandling for atopisk dermatitis Download PDF

Info

Publication number
DK3019185T3
DK3019185T3 DK14747994.3T DK14747994T DK3019185T3 DK 3019185 T3 DK3019185 T3 DK 3019185T3 DK 14747994 T DK14747994 T DK 14747994T DK 3019185 T3 DK3019185 T3 DK 3019185T3
Authority
DK
Denmark
Prior art keywords
combination therapy
atopic dermatitis
atopic
dermatitis
therapy
Prior art date
Application number
DK14747994.3T
Other languages
English (en)
Inventor
Fritz Eichenseher
Mark Leonard Offerhaus
Original Assignee
Micreos Human Health Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48748062&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3019185(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Micreos Human Health Bv filed Critical Micreos Human Health Bv
Application granted granted Critical
Publication of DK3019185T3 publication Critical patent/DK3019185T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/217IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK14747994.3T 2013-07-11 2014-07-10 Kombinationsbehandling for atopisk dermatitis DK3019185T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13176034 2013-07-11
PCT/NL2014/050470 WO2015005787A1 (en) 2013-07-11 2014-07-10 Combination treatment for atopic dermatitis

Publications (1)

Publication Number Publication Date
DK3019185T3 true DK3019185T3 (da) 2021-02-15

Family

ID=48748062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14747994.3T DK3019185T3 (da) 2013-07-11 2014-07-10 Kombinationsbehandling for atopisk dermatitis

Country Status (11)

Country Link
US (2) US10357547B2 (da)
EP (2) EP3789033A1 (da)
KR (2) KR102409340B1 (da)
CN (1) CN105517563A (da)
AU (1) AU2014287845B2 (da)
DK (1) DK3019185T3 (da)
ES (1) ES2853327T3 (da)
IL (1) IL243570B (da)
PL (1) PL3019185T3 (da)
SG (2) SG10202009810YA (da)
WO (1) WO2015005787A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015155244A1 (en) 2014-04-08 2015-10-15 Lysando Ag Pharmaceutical composition against chronic bacterial infections
NO3144387T3 (da) 2015-09-15 2018-08-11
US11208646B2 (en) 2016-05-27 2021-12-28 Sasinapas Co., Ltd. Endolysin variant
WO2018065546A1 (en) 2016-10-07 2018-04-12 Micreos Human Health B.V. Vasoconstricitve and antibacterial combination treatment for rosacea
BR112020021274A2 (pt) * 2018-04-18 2021-04-13 Forte Subsidiary, Inc. Composições para o tratamento de doenças da pele
EP3802814A1 (en) 2018-05-30 2021-04-14 Lysando AG Novel antimicrobial proteins
JP2023518377A (ja) 2020-03-19 2023-05-01 マイクレオス ヒューマン ヘルス ビー.ブイ. 安定化された対象となるタンパク質
IL297430A (en) * 2020-04-20 2022-12-01 Micreos Human Health Bv Chimeric endolysin polypeptide
WO2022195108A2 (en) 2021-03-19 2022-09-22 Eligo Bioscience Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
EP4308135B1 (en) 2021-03-19 2025-12-03 Eligo Bioscience Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins
WO2025093666A1 (en) 2023-11-01 2025-05-08 University Of Copenhagen Treatment of lymphoma
WO2026052743A1 (en) 2024-09-04 2026-03-12 Micreos Human Health B.V. Reduction of trans-epidermal water loss by a polypeptide with antibacterial properties

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428784B1 (en) * 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
KR100910961B1 (ko) * 2007-09-13 2009-08-05 주식회사 인트론바이오테크놀로지 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질
FR2954140A1 (fr) 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
EP2338916A1 (en) 2009-12-23 2011-06-29 Hyglos Invest GmbH Chimeric polypeptides and their use in bacterial decoloniation
DK2705144T4 (da) 2011-05-04 2019-10-21 Micreos Human Health Bv Polypeptid

Also Published As

Publication number Publication date
US20160151463A1 (en) 2016-06-02
EP3019185B1 (en) 2020-11-18
PL3019185T3 (pl) 2021-08-02
AU2014287845A1 (en) 2016-02-11
US20260069666A1 (en) 2026-03-12
EP3789033A1 (en) 2021-03-10
KR102409340B1 (ko) 2022-06-22
KR20160032725A (ko) 2016-03-24
US10357547B2 (en) 2019-07-23
EP3019185A1 (en) 2016-05-18
SG11201600180WA (en) 2016-02-26
SG10202009810YA (en) 2020-11-27
CN105517563A (zh) 2016-04-20
CA2917726A1 (en) 2015-01-15
IL243570B (en) 2020-04-30
ES2853327T3 (es) 2021-09-15
KR20220031725A (ko) 2022-03-11
AU2014287845B2 (en) 2019-11-14
IL243570A0 (en) 2016-03-31
WO2015005787A1 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
GB2528196B (en) Multiple-qubit wave-activated controlled gate
DK3778897T3 (da) Immunonkolytiske terapier
AU356625S (en) Rollator
CL2013001254S1 (es) Unidad de control
CL2013001253S1 (es) Unidad de control
DK3079750T3 (da) Udskyllelige katetre
IL243570A0 (en) Combination treatment for atopic dermatitis
HUE040515T2 (hu) Redõnykapu
LT3563837T (lt) Terapija bakteriofagu
DK3620198T3 (da) Udskyllelige katetre
DE112014003026A5 (de) Steuergerät
BR302014000098S1 (pt) Configuração aplicada em suporte
GB201310755D0 (en) Therapy
DK2976101T3 (da) Behandlingsfremgangsmåde
DK3041506T3 (da) Behandlingsfremgangsmåde
DK3022820T3 (da) Kontrolarrangement
FI20136034A7 (fi) Sauna
UA28711S (uk) Масажер
UA31944S (uk) Регулятор опалення
UA31943S (uk) Регулятор опалення
UA31942S (uk) Регулятор опалення
TH1601000899A (th) อุปกรณ์ควบคุม
TH1501000168B (th) ตู้นิรภัย
TH1601000069A (th) การรักษาร่วมสำหรับโรคผื่นภูมิแพ้ผิวหนัง
BR302013006223S1 (pt) Configuração aplicada em gabarito